About Arvee Laboratories (India) Limited

Arvee Laboratories (India) Limited is a chemicals company headquartered at 403, Entice, Nr. Jayantilal Park BRTS, Iskcon‑Bopal Road, Ambli, Ahmedabad, Gujarat – 380058. It operates through a manufacturing facility at Survey No. 316, Bhavnagar–Shihor Road, Navagam (Kardej), Post Vartej – 364060, Bhavnagar, Gujarat, India. The company confirms that its nature of business is “Chemicals,” with no change during the reporting year. Revenue is generated by both manufacturing and trading activities, reflected in its revenue disclosures for domestic and export sales. Arvee serves national as well as international clients and continues to build on these relationships, underscoring a presence beyond India’s borders. Its disclosures of “Export of Goods on FOB Basis” further indicate active overseas shipments during the year.

The company is listed on the Capital Market Segment (Main Board) of the National Stock Exchange of India Limited (NSE) with the scrip code ARVEE and ISIN INE006Z01016. It has paid the listing fees for 2024–2025 and 2025–2026, and all its shares are dematerialised (100% in demat). In terms of capital history, Arvee issued bonus shares in the ratio of 1:1 on October 14, 2020, as disclosed in its share capital notes.

As at March 31, 2025, Arvee had no subsidiary companies, and therefore consolidated financials and a material subsidiary policy are not applicable. The company’s policy page confirms there is no subsidiary as on the reporting date. The 13th Annual General Meeting (AGM) is scheduled for September 24, 2025, at the registered office in Ahmedabad, with the Annual Report disseminated to eligible members ahead of the meeting.

Key milestones of Arvee Laboratories (India) Limited

• NSE Main Board listing; all equity in demat form.
• 1:1 bonus share issue on October 14, 2020.
• Continued export activities alongside domestic operations, with revenue streams from both manufacturing and trading.
• Manufacturing footprint in Bhavnagar, Gujarat; corporate base in Ahmedabad.

Arvee Laboratories (India) Limited Key Management

• Shalin Sudhakarbhai Patel – Chairman cum Managing Director
• Shalin Bharatbhai Chokshi – Whole Time Director
• Shalin Patel – Chief Financial Officer
• Raina Singh Chauhan – Company Secretary

Latest Updates on Arvee Laboratories (India) Limited

• AGM and shareholder communication: The 13th AGM is scheduled for September 24, 2025, with the Annual Report for 2024–2025 circulated to members whose email addresses are registered; venue is the company’s registered office in Ahmedabad.
• Board and governance changes: The Board recorded the appointment of Mr. Praveen Kumar Rameshchandra Mishra on June 24, 2024; his profile is included in meeting agendas and corporate governance disclosures. The AGM notice also includes resolutions to appoint Mr. Saurin Ajitbhai Gandhi as a Director and to re-appoint Mrs. Neetu Jalan as an Independent Director.
• Corporate governance confirmation: A practicing Company Secretary certified compliance with corporate governance requirements under SEBI (LODR) for the year ended March 31, 2025.
• Listing and capital market compliance: The company reaffirmed that its shares remain listed on the NSE Main Board (scrip: ARVEE) and paid listing fees for 2024–2025 and 2025–2026. All shares are in demat form, with NSDL and CDSL depositories indicated in the shareholding summary.
• Subsidiaries: The company confirms it has no subsidiaries as on March 31, 2025; provisions related to material subsidiaries therefore do not apply.
• Compliance note: The Secretarial Auditor recorded that the Cost Report was not filed in time; it was subsequently filed on April 19, 2025 (SRN: N30325203).
• Operations and clientele: The MD&A reiterates Arvee’s strategy to expand in domestic markets, maintain rigorous quality standards and continue serving national and international clients.